Ask AI
ProCE Banner Activity

Psychedelic Treatments in Psychiatry: ​Clinical Promise, Practical Questions

Slideset

Psychiatric research into psychedelic agents such as psilocybin is rapidly evolving, and the promise of widespread clinical availability is potentially within reach. Learn about their hypothesized mechanisms of action, emerging frameworks for integration into therapeutic practice, and up-to-date clinical trial evidence for the treatment of psychiatric conditions such as major depression, PTSD, and alcohol use disorder.

Released: May 05, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Target Audience

This activity is intended for physicians, physician associates, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review clinical trials and emerging evidence for the use of psychedelic therapies in psychiatry

  • Describe proposed psychological and neurobiological mechanisms of psychedelic agents

  • Examine practice and implementation considerations for incorporation of psychedelic therapy into clinical psychiatry